Provided by Healio
May 22, 2013
ORLANDO, Fla. — P. Patrick Basu, MD, assistant clinical professor of medicine at Columbia University College of Physicians and Surgeons; division chief, department of gastroenterology and GI endoscopy at North Shore University Hospital in Forest Hills, N.Y., discusses his presentation “Romiplostim’s Effect to Optimize SVR With Telaprevir, Ribavirin, and PEG Interferon-Alfa 2A in Thrombocytopenic Cirrhotics With Chronic Hepatitis C. A Placebo Controlled Prospective Clinical Trial: RESTRAINT C Trial.”
No comments:
Post a Comment